TipRanks
Quest Diagnostics (DGX)
NYSE:DGX
US Market
Want to see DGX full AI Analyst Report?

Quest Diagnostics (DGX) Revenue by Segment

1,016 Followers

Revenue by Segment

Shows the revenue contribution from each business segment, indicating which areas are the most lucrative and where the company might focus future growth efforts.
DIS is the clear growth engine—recent quarters show re-acceleration driven by strong volume wins and new diagnostic/commercial rollouts, which prompted management to raise 2026 guidance. That momentum masks a mix shift: large client ramps are boosting volumes but lower revenue-per-requisition and contributed to near-term margin pressure. DS remains flat and immaterial to growth. Key risks to monitor: heavier H2 Project Nova spend, higher fuel costs, reimbursement (PAMA/ACA) uncertainty, and rising DSO affecting cash conversion.
Date
DIS
DS
Sep 30, 2026
$3.04B$62.00M
Jun 30, 2026
$2.98B$65.00M
Mar 31, 2026
$2.83B$63.00M
Dec 31, 2025
$2.74B$64.00M
Sep 30, 2025
$2.75B$61.00M
Jun 30, 2025
$2.70B$62.00M
Mar 31, 2025
$2.59B$63.00M
Dec 31, 2024
$2.56B$65.00M
Sep 30, 2024
$2.43B$61.00M
Jun 30, 2024
$2.33B$64.00M